{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:40:19Z","timestamp":1685562019303},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,4,10]],"date-time":"2010-04-10T00:00:00Z","timestamp":1270857600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Familial Cancer"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s10689-010-9338-5","type":"journal-article","created":{"date-parts":[[2010,4,9]],"date-time":"2010-04-09T11:42:54Z","timestamp":1270813374000},"page":"267-274","source":"Crossref","is-referenced-by-count":5,"title":["Novel germline mutations in BRCA2 gene among breast and breast-ovarian cancer families from Poland"],"prefix":"10.1007","volume":"9","author":[{"given":"Aneta","family":"Balabas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elzbieta","family":"Skasko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorota","family":"Nowakowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Niwinska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pawel","family":"Blecharz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,4,10]]},"reference":[{"key":"9338_CR1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1471-2350-9-58","volume":"9","author":"TVO Hansen","year":"2008","unstructured":"Hansen TVO, Bisgaard ML, Jonson L et al (2008) Novel de novo BRCA2 mutation in a patient with a family history of breast cancer. BMC Med Genet 9:58","journal-title":"BMC Med Genet"},{"key":"9338_CR2","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1055-9965.EPI-06-0783","volume":"16","author":"FJ Couch","year":"2007","unstructured":"Couch FJ, Jonson MR, Rabe KG et al (2007) The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomark Prev 16:342\u2013346","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"5","key":"9338_CR3","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1086\/375033","volume":"72","author":"A Antoniou","year":"2003","unstructured":"Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72(5):1117\u20131130","journal-title":"Am J Hum Genet"},{"key":"9338_CR4","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1073\/pnas.95.9.5287","volume":"95","author":"PL Chen","year":"1998","unstructured":"Chen PL, Chen CF, Chen Y et al (1998) The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment. Proc Natl Acad Sci USA 95:5287\u20135292","journal-title":"Proc Natl Acad Sci USA"},{"key":"9338_CR5","first-page":"85","volume":"14","author":"J Salgado","year":"2005","unstructured":"Salgado J, Zabalegui N, Garcia-Amigot F et al (2005) Structure-based assessment of BRCA1 and BRCA2 mutations in a small Spanish population. Oncol Rep 14:85\u201388","journal-title":"Oncol Rep"},{"key":"9338_CR6","first-page":"995","volume":"59","author":"B Csokay","year":"1999","unstructured":"Csokay B, Udvarhelyi N, Sulyok Z et al (1999) High frequency of germ-line BRCA2 mutations among Hungarian male breast cancer patients without family history. Cancer Res 59:995\u2013998","journal-title":"Cancer Res"},{"key":"9338_CR7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1158\/0008-5472.417.65.2","volume":"65","author":"K Wu","year":"2005","unstructured":"Wu K, Hinson SR, Ohashi A et al (2005) Functional evaluation and cancer risk assessment of BRCA2 unclassified variants. Cancer Res 65:417\u2013426","journal-title":"Cancer Res"},{"key":"9338_CR8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1086\/521032","volume":"81","author":"DF Easton","year":"2007","unstructured":"Easton DF, Deffenbaugh AM, Pruss D et al (2007) A systematic genetic assessment of 1.433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes. Am J Hum Genet 81:873\u2013883","journal-title":"Am J Hum Genet"},{"key":"9338_CR9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/424388","volume":"75","author":"DE Goldgar","year":"2004","unstructured":"Goldgar DE, Easton DF, Deffenbaugh AM et al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75:535\u2013544","journal-title":"Am J Hum Genet"},{"key":"9338_CR10","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1086\/318181","volume":"68","author":"D Thompson","year":"2001","unstructured":"Thompson D, Easton D (2001) Variation in cancer risk, by mutation position, in BRCA2 mutation carriers. Am J Hum Genet 68:410\u2013419","journal-title":"Am J Hum Genet"},{"key":"9338_CR11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1006\/geno.1999.6026","volume":"62","author":"T Wagner","year":"1999","unstructured":"Wagner T, Stoppa-Lyonnet D, Fleischmann E et al (1999) Denaturing high-performance liquid chromatography detects reliably BRCA1 and BRCA2 mutations. Genomics 62:369\u2013376","journal-title":"Genomics"},{"key":"9338_CR12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/jmbi.2000.4042","volume":"302","author":"C Notredame","year":"2000","unstructured":"Notredame C, Higgins DG, Heringa J (2000) T-Coffee: a novel method for fast and accurate multiple sequence alignment. J Mol Biol 302:205\u2013217","journal-title":"J Mol Biol"},{"key":"9338_CR13","unstructured":"BIC (Breast Information Core) database. http:\/\/www.research.nhgri.nih.gov\/bic\/"},{"key":"9338_CR14","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.ejmg.2007.11.001","volume":"51","author":"G Chodick","year":"2008","unstructured":"Chodick G, Struewing JP, Ron E et al (2008) Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976\u20131999. Eur J Med Genet 51:141\u2013170","journal-title":"Eur J Med Genet"},{"key":"9338_CR15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s10689-008-9216-6","volume":"8","author":"T Distelman-Menachem","year":"2009","unstructured":"Distelman-Menachem T, Shapira T, Laitman Y et al (2009) Analysis of BRCA1\/BRCA2 genes\u2019 contribution to breast cancer susceptibility in high risk Jewish Ashkenazi women. Fam Cancer 8:127\u2013133","journal-title":"Fam Cancer"},{"key":"9338_CR16","first-page":"1367","volume":"58","author":"K Haraldsson","year":"1998","unstructured":"Haraldsson K, Loman N, Zhang Q et al (1998) BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. Cancer Res 58:1367\u20131371","journal-title":"Cancer Res"},{"key":"9338_CR17","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1080\/02841860802004974","volume":"47","author":"M Thomassen","year":"2008","unstructured":"Thomassen M, Hansen TVO, Borg A et al (2008) BRCA1 and BRCA2 mutations in Danish families with hereditary breast and\/or ovarian cancer. Acta Oncol 47:772\u2013777","journal-title":"Acta Oncol"},{"key":"9338_CR18","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/1098-1004(200012)16:6<482::AID-HUMU5>3.0.CO;2-O","volume":"16","author":"E Grzybowska","year":"2000","unstructured":"Grzybowska E, Zientek H, Jasi\u0144ska A et al (2000) High frequency of recurrent mutations in BRCA1 and BRCA2 genes in Polish families with breast and ovarian cancer. Hum Mutat 16:482\u2013490","journal-title":"Hum Mutat"},{"key":"9338_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1093\/hmg\/6.1.53","volume":"6","author":"G Bignell","year":"1997","unstructured":"Bignell G, Micklem G, Stratton MR et al (1997) The BRC repeats are conserved in mammalian BRCA2 proteins. Hum Mol Genet 6:53\u201358","journal-title":"Hum Mol Genet"},{"key":"9338_CR20","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/1098-1004(2001)17:1<73::AID-HUMU12>3.0.CO;2-O","volume":"17","author":"E Kwiatkowska","year":"2001","unstructured":"Kwiatkowska E, Teresiak M, Lamperska K et al (2001) BRCA2 germline mutations in male breast cancer patients in the Polish population. Hum Mutat 17:73","journal-title":"Hum Mutat"},{"key":"9338_CR21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S1097-2765(01)00175-7","volume":"7","author":"AA Davies","year":"2001","unstructured":"Davies AA, Masson J-Y, Mcllwraith MJ et al (2001) Role of BRCA2 in control of the RAD51 recombination and DNA repair protein. Mol Cell 7:273\u2013282","journal-title":"Mol Cell"},{"key":"9338_CR22","doi-asserted-by":"crossref","first-page":"R1023","DOI":"10.1186\/bcr1338","volume":"7","author":"B G\u00f3rski","year":"2005","unstructured":"G\u00f3rski B, Narod SA, Lubi\u0144ski J (2005) A common missense variant in BRCA2 predisposes to early onset breast cancer. Breast Cancer Res 7:R1023\u2013R1027","journal-title":"Breast Cancer Res"},{"key":"9338_CR23","first-page":"413","volume":"11","author":"AB Spurdle","year":"2002","unstructured":"Spurdle AB, Hopper JL, Chen X et al (2002) The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60\u00a0years. Cancer Epidemiol Biomark Prev 11:413\u2013416","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"9338_CR24","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/81691","volume":"26","author":"CS Healey","year":"2000","unstructured":"Healey CS, Dunning AM, Teare MD et al (2000) A common variant in BRCA2 is associated with both breast cancer risk and prenatal viability. Nat Genet 26:362\u2013364","journal-title":"Nat Genet"},{"key":"9338_CR25","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2407-7-170","volume":"7","author":"D Palli","year":"2007","unstructured":"Palli D, Falchetti M, Masala G et al (2007) Association between the BRCA2 N372H variant and male breast cancer risk: a population- based case-control study in Tuscany, Central Italy. BMC Cancer 7:170","journal-title":"BMC Cancer"},{"key":"9338_CR26","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/sj.bjc.6600562","volume":"87","author":"A Jakubowska","year":"2002","unstructured":"Jakubowska A, Nej K, Huzarski T et al (2002) BRCA2 gene mutations in families with aggregations of breast and stomach cancers. Br J Cancer 87:888\u2013891","journal-title":"Br J Cancer"}],"container-title":["Familial Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9338-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10689-010-9338-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10689-010-9338-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,31]],"date-time":"2023-05-31T19:07:55Z","timestamp":1685560075000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10689-010-9338-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,10]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["9338"],"URL":"https:\/\/doi.org\/10.1007\/s10689-010-9338-5","relation":{},"ISSN":["1389-9600","1573-7292"],"issn-type":[{"value":"1389-9600","type":"print"},{"value":"1573-7292","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,10]]}}}